Meiji and Arysta enter into new insecticide flupyrimin licensing agreement in India

Japan company Meiji Seika Pharma Co., Ltd. and Arysta LifeScience Corporation announced the signing of a licensing agreement for a new insecticide, “flupyrimin” (development code: ME5382) for use in rice protection in India.   

 

Under this agreement, Meiji will receive an upfront payment as well as developmental milestone. Arysta will obtain the exclusive rights to develop and commercialize flupyrimin. Meiji will supply the active ingredient to Arysta, while Arysta will formulate, promote and sell the products.  

 

Flupyrimin is a new insecticide discovered by Meiji and is under development in Japan (already submitted for registration) and overseas. Flupyrimin is effective against the major insect pests in rice, such as planthoppers and stem borers, including those populations resistant to existing insecticides. Furthermore, flupyrimin is a promising technology due to the low toxicity against honeybees while there are few effective solutions due to growing concerns over the safety to pollinators.  

 

Paddy rice field in India is the largest in the world (44 million hectares annually¹) and India accounts for around 21 percent² of global rice production. In India, rice yields may be reduced by up to 45 percent³ due to insect pests and diseases in which stem borers and planthoppers notably affect over 30 million hectares of rice⁴. Flupyrimin is an innovative solution that is effective in controlling both stem borers in early cultivation stage and planthoppers in mid-to-late stage with one application.   

 

Meiji and Arysta will make further contribution to the development of agriculture in India and make people’s lives better by introducing this innovative technology. Meiji will keep on making the efforts to distribute this technology worldwide and will continue to deliver innovative eco-friendly products.